Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMedOpen access

Rapid cutaneous wound healing in nude mice by fetal skin-derived stem cells involves enhanced collagen secretion and angiogenesis.

Geng Y., Zhang W., Dun X., Wang Y., Shao Y.

Animal Study on Chronic Wound, published in Front Med (Lausanne) (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Front Med (Lausanne) (2025)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
41357483
PMCID
PMC12676943
DOI
10.3389/fmed.2025.1557973

Abstract (original English)

Stem cells are used to treat chronic non-healing wounds. However, the seed cells required for optimal healing remain unknown. In this study, we evaluate the effects of fetal skin-derived stem cells (FSSCs) on a nude mice cutaneous wound model and compare them with adipose-derived mesenchymal stem cells (ADSCs). Both stem cell types exhibit polygonal or spindle-like morphology and differentiate into adipocytes, osteoblasts, and chondrocytes. FSSCs express CD90, CD44, CD73, and CD105, but not CD34, CD45, or CD14. Additionally, they display a lower expression of HLA-DR compared to ADSCs. In vitro , FSSCs have stronger proliferation, migration, and collagen secretion than ADSCs and promote tube formation in human umbilical vein endothelial cells, which is crucial for wound healing. In vivo , FSSCs accelerate cutaneous wound healing in nude mice compared to ADSCs. Furthermore, after intervention with FSSCs, the expression of collagen and angiogenesis-related proteins (CD31 and vascular endothelial growth factor) in the skin tissue significantly increased, and the secretion of inflammatory mediators (TNF-α, IL-6, IL-10, and IL-13) was regulated. Hence, FSSCs are more promising in accelerating wound healing and are closely related to their ability to promote fibroblast proliferation, angiogenesis, and collagen secretion, providing a novel treatment strategy for accelerating wound heal

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research